BRIEF-Regeneron and Sanofi announce Kevzara license application resubmission for review by FDA
* Regeneron and Sanofi announce Kevzara® (sarilumab) Biologics License Application resubmission accepted for review by U.S. FDA
Oct 3 Henderson Global Investors
* Ceo andrew formica says of merger with janus "there is overlap in both our businesses...potential for businesses to grow even faster"
* Ceo andrew formica says janus henderson global investors will have london hq, but maintaining third listing in london "doesn't make sense"
* Ceo andrew formica says merger talks started at beginning of year, not affected by brexit vote Source text for Eikon: Further company coverage:
* Korea stocks, won down after Trump says trade deal needs change
BEIJING, April 28 Toshiba Corp's Westinghouse Electric Co unit will continue operating normally despite the ongoing Chapter 11 restructuring, an executive at the troubled company said on Friday.